Publications
-
The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy
A. Perrin, W. Venderink, M.A. Patak, C. Möckel, J.Fehr, P. Jichlinski, B. Porcellini, I. Lucca, J.J. Fütterer & M. Valerio OBJECTIVES: To evaluate the utility of in-bore multiparametric magnetic resonance-guided biopsy of the prostate (IB) in patients...
-
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy
W. Venderink, J.G.R. Bomers, C.G. Overduin, A.R. Padhani, G.R. de Lauw, J.P.M. Sedelaar & J.O. Barentsz BACKGROUND: After a lesion has been assessed adequately on multiparametric magnetic resonance imaging (mpMRI), magnetic resonance (MR)-guided biopsy...
-
Multiparametric magnetic resonance imaging and follow-up to avoid prostate biopsy in 4259 men
W. Venderink, A. van Luijtelaar, M. van der Leest, J.O. Barentsz, S.F.M. Jenniskens, J.P.M. Sedelaar, C. Hulsbergen-van de Kaa, C.G. Overduin & J.J. Fütterer OBJECTIVE: To determine the proportion of men avoiding biopsy because of negative...
-
Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB
W. Venderink, S.F.M. Jenniskens, J.P.M. Sedelaar, T. Tamada & J.J. Fütterer OBJECTIVE: This study's purposes were to determine the yield of repeat direct in-bore magnetic resonance-guided prostate biopsy (MRGB) (MRGB-2) after the first one was found to...
-
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
M.J. Roobol, S. Eggener, M. Ghei, A. Villers, F. Bladou, G.M. Villeirs, J. Virdi, S. Boxler, G. Robert, P.B. Singh, W. Venderink, B.A. Hadaschik, A. Ruffion, J.C. Hu, D. Margolis, S. Crouzet, L. Klotz, S.S. Taneja, P. Pinto, I. Gill, C. Allen, F....
-
Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer
W. Venderink, A. van Luijtelaar, J.G.R. Bomers, M. van der Leest, C. Hulsbergen-van de Kaa, J.O. Barentsz, J.P.M. Sedelaar & J.J. Fütterer BACKGROUND: The Prostate Imaging Reporting and Data System (PI-RADS) is the most commonly used scoring system in...
-
Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis
W. Venderink, M. de Rooij, J.P.M. Sedelaar, H.J. Huisman & J.J. Fütterer CONTEXT: The main difference between the available magnetic resonance imaging-transrectal ultrasound (MRI-TRUS) fusion platforms for prostate biopsy is the method of image...
-
Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer
W. Venderink, M. van der Leest, A. van Luijtelaar, W.J.M. van de Ven, J.J. Fütterer, J.P.M. Sedelaar & H.J. Huisman PURPOSE: To compare clinically significant prostate cancer (csPCa) detection rates between magnetic resonance imaging (MRI)-transrectal...
-
Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion
W. Venderink, T.M. Govers, M. de Rooij, J.J. Fütterer & J.P.M. Sedelaar OBJECTIVE: Three commonly used prostate biopsy approaches are systematic transrectal ultrasound guided, direct in-bore MRI guided, and image fusion guided. The aim of this study...
-
MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience
W.J.M. van de Ven, W. Venderink, J.P.M. Sedelaar, J. Veltman, J.O. Barentsz, J.J. Fütterer, E.B. Cornel & H.J. Huisman PURPOSE: To evaluate MR-targeted TRUS prostate biopsy using a novel local reference augmentation method. PATIENTS AND METHODS:...